Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 See also  





2 References  














MDAT







Српски / srpski
Srpskohrvatski / српскохрватски
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


MDAT
Clinical data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • 5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxol-6-amine

CAS Number
  • hydrochloride: 3446-21-8 checkY
  • PubChem CID
    ChemSpider
    UNII
  • hydrochloride: BOX4U52EET checkY
  • CompTox Dashboard (EPA)
    Chemical and physical data
    FormulaC11H13NO2
    Molar mass191.230 g·mol−1
    3D model (JSmol)
    • C3Cc1cc2OCOc2cc1CC3N

    6,7-Methylenedioxy-2-aminotetralin (MDAT) is a drug developed in the 1990s by a team at Purdue University led by David E. Nichols.[1] It appears to act as a serotonin releasing agent based on rodent drug discrimination assays comparing it to MDMA, in which it fully substitutes for, and additionally lacks any kind of serotonergic neurotoxicity.[1] Hence, MDAT is considered likely to be a non-neurotoxic, putative entactogen in humans.

    See also[edit]

    References[edit]

    1. ^ a b Nichols DE, Brewster WK, Johnson MP, Oberlender R, Riggs RM (February 1990). "Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry. 33 (2): 703–10. doi:10.1021/jm00164a037. PMID 1967651.

    Retrieved from "https://en.wikipedia.org/w/index.php?title=MDAT&oldid=1216582179"

    Categories: 
    Drugs not assigned an ATC code
    2-Aminotetralins
    Entactogens and empathogens
    Benzodioxoles
    Designer drugs
    Serotonin releasing agents
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Drugs with non-standard legal status
    Articles without EBI source
    Chemical pages without DrugBank identifier
    Articles without KEGG source
    Articles without InChI source
    Multiple chemicals in Infobox drug
    Chemicals using indexlabels
    Chemical articles with multiple CAS registry numbers
    Articles containing unverified chemical infoboxes
     



    This page was last edited on 31 March 2024, at 21:46 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki